Federal Register / Vol. 75, No. 95 / Tuesday, May 18, 2010 / Notices 27797 

onto the NIH campus. All visitor vehicles, 

including taxis, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http://www.

nichd.nih.gov/about/nachhd.htm, where an 

agenda and any additional information for 

the meeting will be posted when available. 

In order to facilitate public attendance at 

the open session of Council, reserve seating 

will be made available to the first five 

individuals reserving seats in the main 

meeting room, Conference Room 6. Please 

contact Ms. Lisa Kaeser, Program and Public 

Liaison Office, NICHD, at 301–496–0536 to 

make your reservation. Additional seating 

will be available in the meeting overflow 

rooms, Conference Rooms 7 and 8. 

Individuals will also be able to view the 

meeting via NIH Videocast. Please go to the 

following link for Videocast access 

instructions at: http://wwwauthor.nichd.nih.

gov/about/overview/advisory/nachhd/virtualmeeting-201005.cfm. The meeting is partially 

closed to the public. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment program, National 

Institutes of Health, HHS) 

Dated: May 12, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–11848 Filed 5–17–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Advisory Commission on Childhood 

Vaccines; Notice of Meeting 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), notice is hereby given 

of the following meeting: 

Name: Advisory Commission on 

Childhood Vaccines (ACCV). 

Date and Time: June 10, 2010, 1 p.m. to 

5:30 p.m. EDT; June 11, 2010, 9 a.m. to 12:30 

p.m. EDT. 

Place: Parklawn Building (and via audio 

conference call), Conference Rooms G & H, 

5600 Fishers Lane, Rockville, MD 20857. 

The ACCV will meet on Thursday, June 10 

from 1 pm to 5:30 pm (EDT) and Friday, June 

11 from 9 a.m. to 12:30 p.m. (EDT). The 

public can join the meeting via audio 

conference call by dialing 1–888–849–8919 

on June 10 & 11 and providing the following 

information: 

Leader’s Name: Dr. Geoffrey Evans. 

Password: ACCV. 

Agenda: The agenda items for the 

December meeting will include, but are not 

limited to: updates from the Division of 

Vaccine Injury Compensation (DVIC), 

Department of Justice, National Vaccine 

Program Office, Immunization Safety Office 

(Centers for Disease Control and Prevention), 

National Institute of Allergy and Infectious 

Diseases (National Institutes of Health), and 

Center for Biologics, Evaluation and Research 

(Food and Drug Administration). Agenda 

items are subject to change as priorities 

dictate. 

Public Comments: Persons interested in 

providing an oral presentation should submit 

a written request, along with a copy of their 

presentation to: Annie Herzog, DVIC, 

Healthcare Systems Bureau (HSB), Health 

Resources and Services Administration 

(HRSA), Room 11C–26, 5600 Fishers Lane, 

Rockville, Maryland 20857 or e-mail: 

aherzog@hrsa.gov. Requests should contain 

the name, address, telephone number, and 

any business or professional affiliation of the 

person desiring to make an oral presentation. 

Groups having similar interests are requested 

to combine their comments and present them 

through a single representative. The 

allocation of time may be adjusted to 

accommodate the level of expressed interest. 

DVIC will notify each presenter by mail or 

telephone of their assigned presentation time. 

Persons who do not file an advance request 

for a presentation, but desire to make an oral 

statement, may announce it at the time of the 

comment period. These persons will be 

allocated time as it permits. 

FOR FURTHER INFORMATION CONTACT: 

Anyone requiring information regarding 

the ACCV should contact Annie Herzog, 

DVIC, HSB, HRSA, Room 11C–26, 5600 

Fishers Lane, Rockville, MD 20857; 

telephone (301) 443–6593 or e-mail: 

aherzog@hrsa.gov. 

Dated: May 11, 2010. 

Sahira Rafiullah, 

Director, Division of Policy and Information 

Coordination. 

[FR Doc. 2010–11837 Filed 5–17–10; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control 

Special Emphasis Panel (SEP): 

Prevention of Suicidal Behavior through 

the Enhancement of Connectedness 

(U01), Request for Applications (RFA) 

CE10–006, initial review. 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the aforementioned meeting: 

Times and Date: 11:30 a.m.–6:30 p.m., 

June 17, 2010 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 

552b(c)(4) and (6), Title 5, U.S.C., and 

the Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Section 10(d) 

of Public Law 92–463. 

Matters To Be Discussed: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

‘‘Prevention of Suicidal Behavior 

through the Enhancement of 

Connectedness (U01), RFA CE10–006’’. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Jane Suen, Dr.P.H., M.S., National 

Center for Injury Prevention and 

Control, Office of the Director, 

Extramural Research Program Office, 

4770 Buford Highway, NE., Mailstop F– 

63, Atlanta, Georgia 30341, Telephone 

(770) 488–4281. 

The Director, Management Analysis 

and Services Office has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities for both CDC and 

the Agency for Toxic Substances and 

Disease Registry. 

Dated: May 11, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–11887 Filed 5–17–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Meeting 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Evaluation of 

Offering and Documenting Influenza 

Vaccination for Nursing Home 

Residents, Funding Opportunity 

Announcement (FOA) IP10–001; 

Development, Implementation, and 

Evaluation of a Multi-Component 

Intervention to Vaccinate Adolescents at 

Risk for Vaccine-Preventable Diseases, 

FOA IP10–002; Evaluation and Impact 

of a State Law Requiring Mandatory 

Influenza Vaccination of Hospital 

Employees, FOA IP10–003; and 

Improving the Translation of the 

mstockstill on DSKH9S0YB1PROD with NOTICES